Trial Condition(s):

Fever, Migraine, Pain

BAY81-8781 Thrombocyte inhibition, pharmacokinetics

Bayer Identifier:

12011

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2006-002057-77

EU CT Number:

Not Available

Study Completed

Trial Purpose

Primary Objective:
To investigate the function of platelets after different single doses of
acetylsalicylic acid (ASA) given as intravenous (IV) BAY 81-8781 and
Aspirin® tablets in comparison to inactive intravenous (IV) treatment.

Secondary Objective:
To investigate safety, tolerability, and pharmacokinetics of these
treatments.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

July2006

December2006

Phase

Could I receive a placebo?

Products

Aspirin (Acetylsalicylic Acid, BAY81-8781)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations
Locations Investigative Site Wuppertal, Germany, 42096	Contact Us: E-mail: [email protected] Phone: Not Available

Investigative Site

Wuppertal, Germany, 42096

Contact Us:

E-mail: [email protected]

Phone: Not Available

Fever, Migraine, Pain

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

40 Years

58 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information